Archive position — measured, not model output
0 likes on Devpost
2,264 of the 7,856 archived projects have more likes, and 5,592 share exactly 0 — so this project's #5,221 place in the like-ranked listing is a tie-break inside that group, not a ranking.
Projects (log scale)
Likes on Devpost. ▲ marks this project's group.
Show the figures
| Likes | Projects | Share of archive |
|---|---|---|
| 0 | 5,592 | 71.2% |
| 1 | 1,758 | 22.4% |
| 2 | 285 | 3.6% |
| 3–4 | 132 | 1.7% |
| 5–9 | 75 | 1.0% |
| 10+ | 14 | 0.2% |
Executive Summary
The description provided is self-reported and unverified. The author states that "medico ai symptom analyser app" is an AI symptom analyser where users input symptoms and the ML model predicts disease outcomes. The project was submitted to the OpenAI 2026 hackathon on Devpost, with no additional information in the write-up beyond the tagline. There is no evidence of revenue, customers, traction or business model.
What the company appears to be
A single-developer project that claims to build an AI-powered symptom analyser app using machine learning, built with Dart, Flask, Flutter and Python packages.
What changed
The project was submitted to a hackathon — this is the only stated change in its lifecycle.
The single most important open question
Is there any evidence of actual functionality or user testing beyond the self-reported description?
What The Product Actually Is
The description states: "its an ai symptom analyser app where by giving symptoms as inputs- the ml will learn the symptoms of disease and predict the output."
This is a self-reported claim. It does not describe the product’s architecture, interface, or technical implementation beyond the use of ML and symptom input.
Evidence The author states that it is an AI symptom analyser app using ML to predict disease outcomes from symptom inputs.
Inference If this were functional, it would likely be a mobile or web application where users enter symptoms and receive a predicted diagnosis or health-related output. However, no evidence of such functionality exists in the description.
Positioning & Claim Evolution
The author states: "its an ai symptom analyser app where by giving symptoms as inputs- the ml will learn the symptoms of disease and predict the output."
This is a single-line positioning statement with no evolution or differentiation described. There is no indication of how this product compares to existing tools, nor any claim about its accuracy, usability, or target audience beyond general symptom analysis.
Evidence The author states that it is an AI symptom analyser app using ML to predict disease outcomes from symptom inputs.
Inference If the project were to evolve, it might be positioned as a diagnostic assistant or health prediction tool. However, no such evolution is evidenced.
Target Customer & ICP
The description does not state who the target customer is or what constitutes an ideal customer profile (ICP).
Evidence Not evidenced.
Inference If this were a real product, it might be aimed at individuals seeking health information or general practitioners needing diagnostic support. However, no such inference is supported by evidence.
Business Model & Pricing Evidence
The description does not contain any information about pricing, monetization, or business model.
Evidence Not evidenced.
Inference If this were a commercial product, it might be sold as a freemium app, subscription, or enterprise tool. However, no such inference is supported by evidence.
Technical & Delivery Signals
The author states that the project was built with: Dart, Flask, Flutter, and Python package index.
Evidence The author states the technologies used in development.
Inference This suggests a mobile application (Flutter), backend API (Flask), and ML integration via Python. However, no evidence of actual delivery or functionality is provided.
Traction & Maturity Signals
The only signal of maturity is that the project was submitted to a hackathon — no further evidence of traction, adoption, or user engagement exists in the description.
Evidence The project was submitted to the OpenAI 2026 hackathon on Devpost.
Inference If this were a mature product, it would have metrics like downloads, active users, or revenue. No such evidence is provided.
Competitive Context
The description does not mention any competitors or how this product fits into the market.
Evidence Not evidenced.
Inference In the health tech or AI diagnostic space, there are many existing tools and platforms. However, no evidence of awareness or positioning relative to them exists in the description.
Key Risks & Red Flags
- The project is described as a single-developer effort with no evidence of team expansion or support.
- No evidence of product functionality, testing, or user feedback.
- No indication of how the ML model was trained or validated.
- No mention of regulatory compliance or data privacy considerations in health-related applications.
- The lack of any business model or monetization strategy raises questions about sustainability.
Evidence Not evidenced.
Diligence Questions To Ask The Founders
- What is the source and quality of training data for the ML model?
- How does the app ensure accuracy and safety in symptom prediction?
- Has the app been tested with real users or validated by medical professionals?
- Is there a plan to scale beyond the hackathon submission?
- What are the legal and ethical considerations around health diagnostics?
- Are there any existing competitors, and how is this project differentiated?
Investment/Partnership Verdict
The description is self-reported and unverified. It does not provide evidence of product functionality, traction, or business model.
Evidence Not evidenced.
Inference At this stage, the project appears to be an idea or prototype submitted for a hackathon. There is no commercial due-diligence basis to support investment or partnership interest without further information.
Source
Submitted to the OpenAI 2026 hackathon on Devpost. Project home on DevPost.
The analysis above was generated by a language model from the project's own one-line description. It is not independent research and contains no verified traction, revenue or customer data.
